Trading Summary - December 23. Overall a slightly better

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
91
Trading Summary - December 23.

Overall a slightly better than satisfactory status quo day for $EVSV even though many traders are already on their Christmas holiday break.

We had yet another update before the open - the 19th hemp update video showing the securely stored first hemp crop from the first grow site - estimated to be between 6,500 and 7,500 pounds - being maintained at the correct moisture level - and confirming further updates soon..

https://twitter.com/EnviroServInc/status/1209104808914935808

The undercut ask that had been walked down to .3000 on Friday was cancelled before the open.

Trading and further manipulation attempts when the ask wasn't hit immediately were recorded contemporaneously in earlier posts.

Multiple new bidders appeared today at .2750 / .2800 / .2900 x 2 - although the expectation of getting filled is minimal given that none of the main traders in $EVSV are going to be duped by nonsense into selling.

Overall, 5,200 shares were bought today - the majority being a 5,000 ask buy at .5350.

The DD / Rolling Brief was updated yesterday and may be found here:

https://investorshangout.com/post/view?id=5625639


Items below the line unchanged since the last long-version Trading Summary:

Top traders of $EVSV have now each earned close to $6-figures on it in the last 3 years and multiple $5-figures already in 2019 - most of which is since the successful r/s 11 months ago - due to multiple surges and the thin share structure for a stock in this price range.

Key Points from recent PRs (not including December 17 PR) are here:

https://investorshangout.com/post/view?id=5619497

The Share Structure was last updated on November 29, 2019 - showing no significant change from the previous update.

The 2019 Q3 was filed on November 18, 2019 in a timely manner.

The 2019 Q2 was filed on August 7, 2019 in a timely manner and gave a very good description of the holding company $EVSV's current portfolio and partnerships (unable to copy - read in filing).

Trading on December 17 illustrated yet again just how difficult it is to accumulate an inventory of 100K > 150K of $EVSV - like the top traders in it have - to be ready for the move to $1+ - within even a .2000 price band increment.

The next buyer of 100K at a time should see .6000 or .7000 up - and the next 200K might see $1+.

The top traders in $EVSV aren't going to waste out time nickel and diming trying to fill on the bid when there is so much else going on with Watch List stocks to attend to daily. We will just take out everything on the ask under 1.000 at a time of our choosing.

Top traders who are the movers and shakers of $EVSV will continue the transfer of more of their profits from other trades into $EVSV up until the first hemp crop revenues come out.

The usual moving around of the insignificant undercut asks by the iHub scammers of course has no effect and they are currently being allowed to continue to post to themselves on iHub completely oblivious to the fact that all traders of significance are networking by other means on telegram and slack.

The modus operandi of the iHub scammers hasn't changed for 11 months since they failed to buy at .0001 on the day before the successful r/s: post blatant nonsense on iHub + attempt to support their fake narrative by trading at or below the visible bid price (often with orders placed before the open + then not pay attention to actual other trading that follows + attempt to walk a small ask down to artificially low levels + not realize that their manipulation attempts don't affect the views of the 160+ social media OTC influencers who have $EVSV on their radar now.

All these manipulation attempts enable top traders on low commission rates - who don't have to worry about partial fills - to just keep accumulating cheap shares almost daily.

As I have warned before, the scammers who attempt paint downs on thin stocks are likely to find themselves detected by their brokers compliance department and reported to the SEC. This is what will then happen:

https://www.sec.gov/news/press-release/2019-216

I'll be mainly #boycottiHub - I have now alerted the more influential / serious Penny Stock Geeks and relevant Whale Team rooms on telegram and slack.

In addition of course we have 172 traders / analysts / alerters on social media that have $EVSV on their radar to start scaling in and / or jumping on board "just-in-time".

Reminder - Tax Loss Disallowed ! You will incur a "wash sale" and have a tax loss disallowed if you:

- Sell any shares that had a purchase cost basis higher than any shares you have bought in the last 30 days.

or

- Buy shares at any price within 30 days of those that you sold for a tax loss.

Warning ! Anyone who is seen posting nonsense on iHub on any on the thinly traded stocks I'm a shareholder in - especially when small paint downs are also seen along with undercut asks - can expect to have their user ID passed to the SEC which has now started to take action against those using the exact modus operandi I have detected and commented on for the past 2 years:

https://www.sec.gov/news/press-release/2019-216




Enviro-Serv, Inc. (EVSV) Stock Research Links

EVSV Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 5

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading

Top 5 Most Recently Viewed Articles

Micro Irrigation Systems: The Future of Sustainable Farming

Updated Category News Views 184

Micro Irrigation Systems: Transforming Global Agriculture The micro irrigation systems market is poised for remarkable growth, expected to expand significantly due to the increasing demand for sustainable agricultural practices. These systems are projected to elevate market valuation from USD 10.9 billion to USD 27.4 billion over the next decade, exhibiting a strong CAGR...

Continue Reading
Empowering Communities: Diaspora Groceries Supplier Summit Launch

Updated Category News Views 276

Empowering Communities: Diaspora Groceries Supplier Summit Launch Diaspora Groceries is thrilled to announce its inaugural Diaspora Diversity Supplier Summit, in partnership with its newly established nonprofit arm, Diaspora Groceries Cares. Taking place over two transformative days, the summit invites food suppliers, farmers, and advocates to gather for insightful...

Continue Reading
EMP Metals Unveils Enhanced Resource Estimate for Lithium Projects

Updated Category News Views 95

EMP Metals Reports Updated Resource Estimate EMP Metals Corp. (CSE: EMPS, OTCQB: EMPPF) is thrilled to share an updated Technical Report detailing the resource estimates for its Viewfield and Mansur lithium brine projects. This comprehensive report showcases a remarkable increase in the total resource, significantly boosting both the indicated and inferred lithium...

Continue Reading
Exploring the Impact of Google Cloud in Enterprise Solutions

Updated Category News Views 264

ISG Evaluates Google Cloud Partner Ecosystem Information Services Group (ISG) (Nasdaq: III), a prominent global technology research and advisory firm, is embarking on an in-depth research study that will gauge the effectiveness of service providers in supporting enterprises using the Google Cloud Platform (GCP) for artificial intelligence (AI) and various other workloads....

Continue Reading
HiRO Joins Forces with CHA University for Future of Health

Updated Category News Views 294

HiRO Collaborates with CHA University Bundang Medical Center Harvest Integrated Research Organization (HiRO), a distinguished global clinical research organization (CRO), has recently entered into a strategic partnership with CHA University Bundang Medical Center (CBMC), a highly respected medical institution in South Korea. This collaboration promises to strengthen the...

Continue Reading